Does the age of onset of growth hormone deficiency affect cardiac performance? A radionuclide angiography study(303 views) Colao A, Cuocolo A, Di Somma C, Cerbone G, Della Morte A, Pivonello R, Nicolai E, Salvatore M, Lombardi G
Keywords: Growth Hormone, Somatomedin C, Adult, Article, Blood Pressure Measurement, Controlled Study, Disease Duration, Electrocardiogram, Exercise, Female, Groups By Age, Growth Hormone Deficiency, Heart Development, Heart Left Ventricle Ejection Fraction, Heart Performance, Heart Rate, Hormone Blood Level, Human, Major Clinical Study, Onset Age, Priority Journal, Scintiangiography, Age Of Onset, Analysis Of Variance, Case-Control Studies, Cross-Sectional Studies, Electrocardiography, Gated Blood-Pool Imaging, Heart Diseases, Insulin-Like Growth Factor I, Middle Aged,
Affiliations: Dept. of Molec./Clin. Endocrinol./O., Dept. of Biomorphological/Funct. S., Pozzilli, Italy
Nucl. Med. Ctr. of the Natl. C., Dept. of Biomorphological/Funct. S., 'Federico II' University of Naples, Pozzilli, Italy
INM Neuromed, Pozzilli, Italy
Dept. of Molec. /Clin. Endocrinol. /O., Dept. of Biomorphological/Funct. S., Pozzilli, Italy
References: Aimaretti, G., Corneli, G., Razzore, P., Bellone, S., Baffoni, C., Arvat, E., Camanni, F., Ghigo, E., Comparison between insulin-induced hypoglycemia and growth hormone (GH) -releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults (1998) Journal of Clinical Endocrinology and Metabolism, 83, pp. 1615-161
Amato, G., Carella, C., Fazio, S., La Montagna, G., Cittadini, A., Sabatini, D., Marciano-Mone, C., Bellastella, A., Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses (1993) Journal of Clinical Endocrinology and Metabolism, 77, pp. 1671-1676
Bacharach, S.L., Green, M.V., Borer, J.S., Hyde, J.E., Farkas, S.P., Johnston, G.S., Left ventricular peak ejection rate, filling rate and ejection fraction: Frame requirements at rest and exercise (1979) Journal of Nuclear Medicine, 20, pp. 1889-1893
Bates, A.S., Vant'Hoff, W., Jones, P.J., Clayton, R.N., The effect of hypopituitary on life expectancy (1996) Journal of Clinical Endocrinology and Metabolism, 81, pp. 1169-1172
Bengtsson, B., Edén, S., Lonn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Isaksson, O.G., Treatment of adults with growth hormone (GH) deficiency with recombinant human GH (1993) Journal of Clinical Endocrinology and Metabolism, 76, pp. 309-317
Bengtsson, B.A., Christiansen, J.S., Cuneo, R.C., Saccà, L., Cardiovascular effects of GH (1997) Journal of Endocrinology, 152, pp. 1-3
Böger, R.H., Skamira, C., Bode-Böger, S.M., Brabant, C., Von Zur Muhlen, A., Frolich, J.C., Nitric oxide mediates the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency (1996) Journal of Clinical Investigation, 98, pp. 2706-2713
Bonow, R.O., Bacharach, S.L., Green, M.V., Kent, K.M., Rosing, D.R., Lipson, L.C., Leon, M.B., Epstein, S.E., Impaired left ventricular diastolic filling in patients with coronary artery disease: Assessment with radionuclide angiography (1981) Circulation, 64, pp. 315-323
Bonow, R.O., Vitale, D.F., Bacharach, S.L., Frederick, T.M., Kent, K.M., Green, M.V., Asynchronous left ventricular regional function and impaired global diastolic filling in patients with coronary artery disease: Reversal after coronary angioplasty (1985) Circulation, 71, pp. 297-307
Borson-Chazot, F., Serusclat, A., Kalfallah, Y., Ducottet, X., Sassolas, G., Bernard, S., Labrousse, F., Berthezéne, F., Decrease in carotid intima-media thickness after 1 year growth hormone (GH) treatment in adults with GH deficiency (1999) Journal of Clinical Endocrinology and Metabolism, 84, pp. 1329-1333
Bülow, B., Hagmar, L., Mikoczy, Z., Nordström, C.H., Erfurth, E.M., Increased cerebrovascular mortality in patients with hypopituitarism (1997) Clinical Endocrinology, 46, pp. 75-81
Carrol, P.V., Christ, E.R., Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review (1998) Journal of Clinical Endocrinology and Metabolism, 83, pp. 382-395
Cittadini, A., Cuocolo, A., Merola, B., Fazio, S., Sabatini, D., Nicolai, E., Colao, A., Saccà, L., Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement (1994) American Journal of Physiology, 267, pp. E219-E225
Colao, A., Cerbone, G., Pivonello, R., Klain, M., Aimaretti, G., Faggiano, A., Di Somma, C., Lombardi, G., Growth hormone deficiency in elderly patients with hypothalamo-pituitary tumors (1998) Pituitary, 1, pp. 59-67
Colao, A., Lombardi, G., GH and PRL excess (1998) Lancet, 352, pp. 1455-1461
Colao, A., Cuocolo, A., Di Somma, C., Cerbone, G., Della Morte, A.M., Nicolai, E., Lucci, R., Lombardi, G., Impaired cardiac performance in elderly patients with growth hormone deficiency (1999) Journal of Clinical Endocrinology and Metabolism, 85, pp. 3950-3955
Colao, A., Di Somma, C., Pivonello, R., Loche, S., Aimaretti, G., Cerbone, G., Faggiano, A., Lombardi, G., Bone loss is correlated to the severity of growth hormone (GH) deficiency in adult patients with hypopituitarism (1999) Journal of Clinical Endocrinology and Metabolism, 84, pp. 1919-1924
Cuocolo, A., Nicolai, E., Colao, A., Longobardi, S., Cardei, S., Fazio, S., Merola, B., Salvatore, M., Improved left ventricular function after growth hormone replacement in patients with hypopituitarism: Assessment with radionuclide angiography (1996) European Journal of Nuclear Medicine, 23, pp. 390-394
De Boer, H., Blok, G., Van Der Veen, E.A., Clinical aspects of growth hormone deficiency in adults (1995) Endocrine Review, 16, pp. 63-86
Feigenbaum, H., (1979) Echocardiography. 2nd Edn., , Lea and Febiger, Philadelphia
Fort, S., Weaver, J.U., Monson, J.P., Mills, P.G., The effects of low dose recombinant human growth hormone on cardiovascular structure and function in hypopituitary growth hormone-deficient adults (1995) Endocrinology and Metabolism, 2, pp. 119-126
Consensus guidelines for diagnosis and treatment of adults with GH deficiency (1998) Journal of Clinical Endocrinology and Metabolism, 83, pp. 379-381
Guse, A.H., Kiess, W., Funk, B., Kessler, U., Berg, I., Gercken, G., Identification and characterization of insulin-like growth factor receptors on adult rat myocytes: Linkage to inositol-1,4,5-trisphosphate formation (1992) Endocrinology, 130, pp. 145-151
Hanson, M.C., Kenneth, A.F., Alexander, R.W., DeLafontaine, P., Induction of cardiac insulin-like growth factor-I gene expression in pressure overload hypertrophy (1993) American Journal of Medical Science, 306, pp. 69-74
Isgaard, J., Nilsson, A., Vickman, K., Isaksson, O.G.P., Growth hormone regulates the level of insulin-like growth factor-I mRNA in rats skeletal muscle (1989) Journal of Endocrinology, 120, pp. 107-112
Ito, H., Hiroe, M., Hirata, Y., Tsujino, M., Aduchi, S., Shichiri, M., Koike, A., Marumo, F., Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes (1993) Circulation, 87, pp. 1715-1721
Lombardi, G., Colao, A., Cuocolo, A., Longobardi, S., Di Somma, C., Orio, F., Merola, B., Salvatore, M., Cardiological aspects of growth hormone and insulin-like growth factor-1 (1997) Journal of Pediatric Endocrinology and Metabolism, 10, pp. 553-560
Longobardi, S., Cuocolo, A., Merola, B., Di Rella, F., Colao, A., Nicolai, E., Cardei, S., Lombardi, G., Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency (1998) Clinical Endocrinology, 48, pp. 137-143
Mayoux, E., Ventura-Clapier, R., Timsit, J., Behar-Cohen, H., Hoffman, C., Mercadier, J.J., Mechanical properties of rat cardiac skinned fibers altered by chronic growth hormone hypersecretion (1993) Circulation Research, 72, pp. 57-64
Markussis, V., Beshiah, S.A., Fisher, C., Sharp, P., Niccolaides, A.N., Johnston, D.G., Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults (1992) Lancet, 340, pp. 1188-1192
Mathews, L.S., Enmberg, B., Norstedt, G., Regulation of rat growth hormone receptor gene expression (1989) Journal of Biological Chemistry, 17, pp. 9905-9910
Merola, B., Cittadini, A., Colao, A., Longobardi, S., Fazio, S., Sabatini, D., Saccà, L., Lombardi, G., Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency (1993) Journal of Clinical Endocrinology and Metabolism, 77, pp. 1658-1661
Merola, B., Longobardi, S., Sofia, M., Pivonello, R., Micco, A., Di Rella, F., Esposito, V., Lombardi, G., Lung volumes and respiratory muscle strength in adult patients with childhood or adulthood onset GH deficiency. Effect of 12 months GH replacement therapy (1996) European Journal of Endocrinology, 135, pp. 553-558
Miller, T.R., Grossman, S.G., Schechtmun, K.B., Biello, D.R., Ludbrook, P.A., Ehansi, A.A., Left ventricular diastolic filling and its association with age (1986) American Journal of Cardiology, 58, pp. 531-535
Moller, J., Frandsen, E., Fisker, S., Jorgensen, J.O.L., Christiansen, J.S., Decreased plasma dna extracellular volume in growth hormone deficient adults and the acute and prolonged effects of gh administration: A controlled experimental study (1996) Clinical Endocrinology, 44, pp. 533-539
Pfeifer, M., Verhovec, R., Zizek, B., Prezelj, J., Poredoö, P., Clayton, R.N., Growth hormone (GH) treatment reverses early atherosclerotic changes in GH deficient adults (1999) Journal of Clinical Endocrinology and Metabolism, 84, pp. 453-457
Rosén, T., Bengtsson, B.A., Premature mortality due to cardiovascular disease in hypopituitarism (1990) Lancet, 336, pp. 285-288
Rosén, T., Eden, S., Larson, G., Wilhelmsen, L., Bengtsson, B.A., Cardiovascular risk factors in adult patients with growth hormone deficiency (1993) Acta Endocrinologica, 129, pp. 195-200
Saccà, L., Cittadini, A., Fazio, S., Growth hormone and the heart (1994) Endocrine Review, 15, pp. 555-573
Shahi, M., Beshyah, S., Hackett, D., Sharp, P., Johnston, D., Foale, R., Myocardial dysfunction in treated adult hypopituitarism: A possible explanation for increased cardiovascular mortality (1992) British Heart Journal, 67, pp. 92-96
Timsit, J., Riou, B., Bertherat, J., Wisnewsky, C., Kato, N.S., Weisberg, A.S., Lubetzki, J., Mercadier, J.J., Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern and myosin-adenosin thriphosphatase activity of rat left ventricle (1990) Journal of Clinical Investigation, 86, pp. 507-515
Toogood, A.A., Adams, J.E., O'Neill, P.A., Shalet, S.M., Body composition in growth hormone deficient adult over the age of 60 years (1996) Clinical Endocrinology, 45, pp. 399-405
Valcavi, R., Gaddi, O., Zini, M., Iavicolli, M., Mellino, U., Portioli, I., Cardiac performance and mass in adult with hypopituitarism: Effects of one year of growth hormone treatment (1995) Journal of Clinical Endocrinology and Metabolism, 80, pp. 659-666
Vetter, U., Kupferschmid, C., Lang, D., Pents, S., Insulin-like growth factors and insulin increase the contractility of neonatal rat cardiocytes in vitro (1988) Basic Research in Cardiology, 83, pp. 647-654
Bacharach, S. L., Green, M. V., Borer, J. S., Hyde, J. E., Farkas, S. P., Johnston, G. S., Left ventricular peak ejection rate, filling rate and ejection fraction: Frame requirements at rest and exercise (1979) Journal of Nuclear Medicine, 20, pp. 1889-1893
Bates, A. S., Vant'Hoff, W., Jones, P. J., Clayton, R. N., The effect of hypopituitary on life expectancy (1996) Journal of Clinical Endocrinology and Metabolism, 81, pp. 1169-1172
Bengtsson, B., Ed n, S., Lonn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Isaksson, O. G., Treatment of adults with growth hormone (GH) deficiency with recombinant human GH (1993) Journal of Clinical Endocrinology and Metabolism, 76, pp. 309-317
Bengtsson, B. A., Christiansen, J. S., Cuneo, R. C., Sacc, L., Cardiovascular effects of GH (1997) Journal of Endocrinology, 152, pp. 1-3
B ger, R. H., Skamira, C., Bode-B ger, S. M., Brabant, C., Von Zur Muhlen, A., Frolich, J. C., Nitric oxide mediates the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency (1996) Journal of Clinical Investigation, 98, pp. 2706-2713
Bonow, R. O., Bacharach, S. L., Green, M. V., Kent, K. M., Rosing, D. R., Lipson, L. C., Leon, M. B., Epstein, S. E., Impaired left ventricular diastolic filling in patients with coronary artery disease: Assessment with radionuclide angiography (1981) Circulation, 64, pp. 315-323
Bonow, R. O., Vitale, D. F., Bacharach, S. L., Frederick, T. M., Kent, K. M., Green, M. V., Asynchronous left ventricular regional function and impaired global diastolic filling in patients with coronary artery disease: Reversal after coronary angioplasty (1985) Circulation, 71, pp. 297-307
B low, B., Hagmar, L., Mikoczy, Z., Nordstr m, C. H., Erfurth, E. M., Increased cerebrovascular mortality in patients with hypopituitarism (1997) Clinical Endocrinology, 46, pp. 75-81
Carrol, P. V., Christ, E. R., Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review (1998) Journal of Clinical Endocrinology and Metabolism, 83, pp. 382-395
Guse, A. H., Kiess, W., Funk, B., Kessler, U., Berg, I., Gercken, G., Identification and characterization of insulin-like growth factor receptors on adult rat myocytes: Linkage to inositol-1, 4, 5-trisphosphate formation (1992) Endocrinology, 130, pp. 145-151
Hanson, M. C., Kenneth, A. F., Alexander, R. W., DeLafontaine, P., Induction of cardiac insulin-like growth factor-I gene expression in pressure overload hypertrophy (1993) American Journal of Medical Science, 306, pp. 69-74
Mathews, L. S., Enmberg, B., Norstedt, G., Regulation of rat growth hormone receptor gene expression (1989) Journal of Biological Chemistry, 17, pp. 9905-9910
Miller, T. R., Grossman, S. G., Schechtmun, K. B., Biello, D. R., Ludbrook, P. A., Ehansi, A. A., Left ventricular diastolic filling and its association with age (1986) American Journal of Cardiology, 58, pp. 531-535
Newman, C. B., Kleinberg, D. L., Adult growth hormone deficiency (1998) Endocrinologist, 8, pp. 178-186
Ros n, T., Bengtsson, B. A., Premature mortality due to cardiovascular disease in hypopituitarism (1990) Lancet, 336, pp. 285-288
Ros n, T., Eden, S., Larson, G., Wilhelmsen, L., Bengtsson, B. A., Cardiovascular risk factors in adult patients with growth hormone deficiency (1993) Acta Endocrinologica, 129, pp. 195-200
Sacc, L., Cittadini, A., Fazio, S., Growth hormone and the heart (1994) Endocrine Review, 15, pp. 555-573
Toogood, A. A., Adams, J. E., O'Neill, P. A., Shalet, S. M., Body composition in growth hormone deficient adult over the age of 60 years (1996) Clinical Endocrinology, 45, pp. 399-405
Does the age of onset of growth hormone deficiency affect cardiac performance? A radionuclide angiography study
BACKGROUND: GH and IGF-I seem to play a relevant role in cardiac development and performance. Longstanding GH deficiency (GHD) causes several abnormalities in cardiac structure and performance which ultimately determine an increased cardiovascular morbidity and mortality. OBJECTIVE: To investigate whether the age of onset of GHD plays a role in determining the negative effects on the heart. DESIGN: Open cross-sectional PATIENTS: 55 patients with adulthood-onset GHD and 36 healthy sex- and age-matched controls. Patients and controls were divided into 2 groups in line with age: 32 patients and 16 controls, were aged ≤ 35 years (young); while 23 patients and 20 controls were aged between 36 and 60 years (middle-aged). The estimated disease duration was similar in young (6.7 ± 0.5 years) and middle-aged patients (8.1 ± 1.2 years, P = 0.2). STUDY PROTOCOL: All subjects underwent ECG, blood pressure and heart rate measurement, plasma IGF-I level assay, and equilibrium radionuclide angiography. RESULTS: Plasma IGF-I levels were significantly lower in patients than in controls (P < 0.0001). When considered as a whole, no difference in systolic (SBP) and diastolic blood pressure (DBP) at peak exercise was found between patients and controls. However, a significant decrease of SBP at rest was found in young patients as compared to age-matched controls (P = 0.009), while a significant increase of DBP at rest was found in middle-aged patients as compared to age-matched controls (P = 0.03). In addition, in young patients, both resting (P = 0.02) and exercise heart rate (P = 0.01) were significantly lower than in controls. Diastolic filling when measured as end-diastolic volume (EVD/sec), was significantly reduced in middle-aged patients (P = 0.04). An impaired peak filling rate (PFR) (<2.5 EDV/sec) was found in 30 patients (54.5%) and 10 controls (27.7%, χ2 = 5.3, P = 0.02): 17 young (53.1%) and 13 middle-aged patients (56.5%). A significant decrease of left ventricular (LV) ejection fraction (EF) at peak exercise was found in both patients groups (P < 0.0001) while LVEF at rest was lower only in middle-aged patients (P = 0.004). An impaired LVEF at rest (<50%) was found in 13 patients (23.6%) and in none of controls (χ2 = 8.1, P = 0.004). The exercise induced changes in LVEF (ΔEF) were significantly lower in both patients groups than in age-matched controls (P < 0.0001). Impaired LVEF response to exercise (<5% increase vs. basal value) was found in 36 patients (65.4%) and in 5 controls (13.8%, χ2 = 21.3, P < 0.000): 21 young (65.6%) and 15 middle-aged patients (65.2%). The peak ejection rate (PER) was also significantly lower in young GHD patients than in controls (P < 0.001). Exercise duration and capacity were significantly reduced in both groups of GHD patients. In the patient group, age was significantly correlated with SBP and DBP levels both at rest (r = 0.612, and r = 0.516, respectively, P < 0.001) and at peak exercise (r = 0.4, P < 0.005 and r = 0.34, P < 0.01, respectively), with exercise duration (r = -0.383, P < 0.005) and capacity (r = -0.355, P = 0.005). Disease duration was also correlated with IGF-I levels (r = -0.319, P < 0.01), SBP levels at peak exercise (r = -0.352, P = 0.005), and LVEF at rest (r = -0.254, P < 0.05). Finally, a significant correlation was found between IGF-I levels and DBP at peak exercise (r = 0.3, P < 0.05) and between GH peak at ARG + GHRH test and LVEF at rest (r = 0.232, P < 0.05). Exercise-induced changes in LVEF were significantly correlated with SBP levels at peak exercise (r = -0.401, P < 0.005), PFR expressed as EDV/sec (r = -0.306, P < 0.05) and SV/sec (r = -0.292, P < 0.05). At multiple regression analysis in the patient group, age was the strongest predictor of SBP both at rest (t = 4.17, P < 0.0001) and at peak exercise (t = 2.32, P = 0.025), and capacity (t = -2.84, P = 0.007). IGF-I levels were the strongest predictor of DBP at peak exercise (t = 2.2, P = 0.03). CONCLUSIONS: Diastolic filling abnormalities and impaired left ventricular ejection fraction response at peak exercise were found in the majority of patients with GHD acquired in adulthood, regardless of the patients age and age of disease onset. On this basis a careful cardiological assessment of GHD adult patients by radionuclide angiography can be helpful in diagnosing early stages of cardiac failure which could then be monitored during GH replacement therapy.
Does the age of onset of growth hormone deficiency affect cardiac performance? A radionuclide angiography study
No results.
Does the age of onset of growth hormone deficiency affect cardiac performance? A radionuclide angiography study
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(284 views) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 ViewExport to BibTeXExport to EndNote
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G * CaMK4 gene deletion induces hypertension(349 views) J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D. Impact Factor:2.882 ViewExport to BibTeXExport to EndNote
Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G * Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation(849 views) Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806. Impact Factor:8.017 ViewExport to BibTeXExport to EndNote
Aloj L, Aurilio M, Rinaldi V, D'Ambrosio L, Tesauro D, Peitl PK, Maina T, Mansi R, Von Guggenberg E, Joosten L, Sosabowski JK, Breeman WA, De Blois E, Koelewijn S, Melis M, Waser B, Beetschen K, Reubi JC, De Jong M * The EEE project(449 views) Proc Int Cosm Ray Conf Icrc Universidad Nacional Autonoma De Mexico, 2007; 5(HEPART2): 977-980. Impact Factor:0 ViewExport to BibTeXExport to EndNote
Vitiello M, Finamore E, Falanga A, Raieta K, Cantisani M, Galdiero F, Pedone C, Galdiero M, Galdiero S * Fusion in Coq(479 views) Lecture Notes In Computer Science (ISSN: 0302-9743, 0302-974335404636319783540463634, 0302-974335402975459783540297543), 2001; 2178LNCS: 583-596. Impact Factor:0.415 ViewExport to BibTeXExport to EndNote